Biotricity is a medical technology company focused on biometric data monitoring solutions. Co. delivers remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Co.'s Bioflux is an integrated electrocardiogram device and software solution for the mobile cardiac telemetry market. The Bioflux platform has a built-in cellular chipset and a real-time embedded operating system which allows for Co.'s technology to be utilized as an Internet of Things platform. This technology can be utilized into other applications and industries by utilizing the platform and OS side of Bioflux. The BTCY stock yearly return is shown above.
The yearly return on the BTCY stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2023 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the BTCY annual return calculation with any dividends reinvested as applicable (on ex-dates).
|